Rapid Dose Therapeutics Corp. is a Canadian biotechnology company, which engages in providing innovative, proprietary, and drug-delivery technologies designed to improve outcomes and quality of lives. It owns a proprietary oral fast dissolving drug delivery system, QuickStrip. It operates through the following business segments: Health and Wellness, White Label, and MSSA. The Health and Wellness segment includes nutraceuticals and infused soaps. The White Label segment refers to the selling of oral thin film strips containing active ingredients under cannabis licensing. The MSSA segment is involved in MSSA contracts, and licensing and other related services. The company was founded by Mark Upsdell on February 27, 2008 and is headquartered in Burlington, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Rapid Dose Therapeutics Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rapid Dose Therapeutics Corp market cap is $23.32M.
What is the 52-week high for Rapid Dose Therapeutics Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rapid Dose Therapeutics Corp 52 week high is $0.325 as of September 08, 2025.
What is the 52-week low for Rapid Dose Therapeutics Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rapid Dose Therapeutics Corp 52 week low is $0.125 as of September 08, 2025.
What is Rapid Dose Therapeutics Corp stock price today?
Rapid Dose Therapeutics Corp stock price today is $0.18.
What was Rapid Dose Therapeutics Corp stock price yesterday?
Rapid Dose Therapeutics Corp stock price yesterday was $0.17.
What is the PE ratio of Rapid Dose Therapeutics Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rapid Dose Therapeutics Corp’s P/E ratio is -4.69.
What is the Price-to-Book ratio of Rapid Dose Therapeutics Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rapid Dose Therapeutics Corp P/B ratio is -4.4610.
What is the 50-day moving average of Rapid Dose Therapeutics Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rapid Dose Therapeutics Corp 50-day moving average is $0.1873.